In Vitro Cytotoxic Effect of Andrographolide On MDA-MB-231-LM2 Breast Cancer Cells and Its Formulation and Characterization As An Emulsion doi.org/10.26538/tjnpr/v4i1.1
Main Article Content
Abstract
Andrographolide, a potential chemotherapeutic agent elicits its anticancer activity on various cancer types by activating multiple cell death pathways thereby possessing the intrinsic ability to combat resistance. The andrographolide molecule however is poorly soluble in water (74 µg/mL) resulting in reduced efficacy; hence, the need for its formulation into appropriate dosage form. The study is aimed at investigating the in vitro cytotoxic potency of andrographolide on MDA-MB-231-LM2 breast cancer cells with subsequent formulation and characterization of andrographolide emulsions. In vitro cytotoxic effect of andrographolide on MDA-MB-231-LM2 breast cancer cells was investigated via the MTS (3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4- sulfophenyl)-2H-tetrazolium) assay, andrographolide was formulated as an emulsion using olive oil, castor oil and liquid paraffin respectively. The formulations were characterized by determining the emulsion type, particle size, flow rate, viscosity and andrographolide content. Andrographolide was found to be cytotoxic to MDA-MB-231-LM2 breast cancer cells having an IC50 (concentration required to cause 50% reduction in viable cells) value of 25.96 µM. The formulations contained particles between 6.53 to 14.4 µm size; formulations containing olive oil and liquid paraffin had smaller particle size and higher viscosity than the castor oil formulation. The olive oil emulsion had lower flow rate. All formulations were of the oil-in-water emulsion type containing 98.3 – 104.2% andrographolide. Andrographolide exhibits cytotoxic activity on MDA-MB-231-LM2 cells. Its emulsion formulations containing olive oil and liquid paraffin as oil phase possess desirable physicochemical properties than the castor oil formulation.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
National Cancer Institute. Definition of lab-on-a-chip - NCI Dictionary of Cancer Terms. [Online]. 2018 [cited 2019 Oct 30]. Available from: https://www.cancer.gov/publications/dictionaries/cancer- terms/def/chemotherapy.
Sugerman DT. Chemotherapy. JAMA. 2013; 310(2):218.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394–424.
Nounou MI, Elamrawy F, Ahmed N, Abdelraouf K, Goda S, Syed-Sha-Qhattal H. Breast cancer: Conventional diagnosis and treatment modalities and recent patents and technologies supplementary issue: Targeted therapies in breast cancer treatment. Breast Cancer Basic Clin Res. 2015; 9:17–34.
Takimoto BCH, Calvo E. Principles of oncologic pharmacotherapy. Oncology. 2005; 1–16.
Bhatia S. Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications. In: Natural Polymer Drug Delivery Systems: Nanoparticles, Plants, and Algae. Switzerland: Springer International; 2016. 33–93 p.
McGowan EM, Alling N, Jackson EA, Yagoub, Daniel Haass, Nikolas K. Allen, John D. Martinello-Wilks R. Evaluation of cell cycle arrest in estrogen responsive MCF- 7 breast cancer cells: Pitfalls of the MTS assay. PLoS One. 2011; 6(6):1–8.
Nurgali K, Jagoe RT, Abalo R. Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae? Front Pharmacol. 2018; 9(245):1–3.
Azim HA, de Azambuja E, Colozza M, Bines J, Piccart MJ. Long-term toxic effects of adjuvant chemotherapy in breast cancer. Ann Oncol of J Eur Soc Med Oncol. 2011; 22(9):1939–1947.
Jarukamjorn K, Nemoto N. Pharmacological Aspects of Andrographis paniculata on Health and Its Major Diterpenoid Constituent Andrographolide. J Heal Sci. 2008; 54(4):370–381.
Niranjan A, Tewari SK, Lehri A. Biological activities of Kalmegh (Andrographis paniculata Nees) and its active principles-A review. Indian J Nat Prod Resour. 2010; 1(2):125–135.
Pawar A, Rajalakshmi S, Mehta P, Shaikh K, Bothiraja C. Strategies for formulation development of andrographolide. RSC Adv. 2016; 6(73):69282–69300.
Ajaya Kumar R, Sridevi K, Vijaya Kumar N, Nanduri S, Rajagopal S. Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol. 2004; 92(2/3):291–295.
Cheung HY, Cheung SH, Li J, Cheung CS, Lai WP, Fong WF. Andrographolide Isolated from Andrographis paniculata Induces Cell Cycle Arrest and Mitochondrial- Mediated Apoptosis in Human Leukemic HL-60 Cells. Planta Med. 2005; 71(12):1106–1111.
Sheeja K, Kuttan G. Activation of Cytotoxic T Lymphocyte Responses and Attenuation of Tumor Growth in vivo by Andrographis paniculata Extract and Andrographolide. Immunopharmacol Immunotoxicol. 2007; 29(1):81–93.
Zhou J, Lu GD, Ong CS, Ong CN, Shen HM. Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation. Mol Cancer Ther. 2008; 7(7):2170–2180.
Hu X, Xuan Y. Mini-review Bypassing cancer drug resistance by activating multiple death pathways-A proposal from the study of circumventing cancer drug resistance by induction of necroptosis. Cancer Lett. 2008; 259:127–137.
Ghosh P, Mondal S, Bera T. Preparation and characterization of andrographolide nanoparticles for visceral leishmaniasis chemotherapy: In vitro and in vivo evaluations. Int J Pharm Pharm Sci. 2016; 8(12):102–107.
Barkat AK. Basics of pharmaceutical emulsions: A review. African J Pharm Pharmacol. 2011; 5(25):2715–2725.
Welsh JE. Animal Models for Studying Prevention and Treatment of Breast Cancer. In: Animal Models for the Study of Human Disease. Elsevier Inc; 2013. 997–1018 p.
Lim JCW, Chan TK, Ng DS, Sagineedu SR, Stanslas J, Wong WF. Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer. Clin Exp Pharmacol Physiol. 2012; 39(3):300–310.
International Conference on Harmonization. ICH Topic Q 2 (R1) Validation of Analytical Procedures: Text and Methodology Step 5 Note for Guidance on Validation of Analytical Procedures: Text and Methodology (CPMP/ICH/381/95) [Online]. 1995 [cited 2019 Oct 30]. Available from: http://www.emea.eu.int.
Sivakumaran N, Samarakoon SR, Adhikari A, Ediriweera MK, Tennekoon. Cytotoxic and Apoptotic Effects of Govaniadine Isolated from Corydalis govaniana Wall. Roots on Human Breast Cancer (MCF-7) Cells. Biomed Res Int. 2018; 2018:1–12.
Banerjee M, Chattopadhyay S, Choudhuri T, Bera R, Kumar S, Mukherjee SK. Cytotoxicity and cell cycle arrest induced by andrographolide lead to programmed cell death of MDA-MB-231 breast cancer cell line. J Biomed Sci. 2016; 23(1):40.
Madaan V, Chanana A, Kataria MK, Bilandi A. Emulsion Technology and Recent Trends in Emulsion Applications. Int Res J Pharm. 2014; 5(7):533–542.
Aulton ME. Pharmaceutics : the science of dosage form design. (2nd ed.). New York: Churchill Livingstone; 2002. 679 p.
Azubuike C, Alfa M, Oseni B. Characterization and Evaluation of the Suspending Potentials of Corchorus olitorius Mucilage in Pharmaceutical Suspensions. Trop J Nat Prod Reseach. 2017; 1(1):39–46.
Icelli O, Yalcin Z, Karakaya V, Ilgaz IP. The spectral applications of Beer-Lambert law for some biological and dosimetric materials. In: AIP Conference Proceedings. American Institute of Physics Inc; 2014. 199–203 p.